Drug Product
Analytical & Bioanalytical Services
Clinical Trial Supply & Logistics
Regulatory, Tech Transfer & Support Services
Company Overview
About
Mabion S.A. is a pharmaceutical CDMO offering comprehensive services.
Key Expertise
Specialized in Gene Therapy, Cell Therapy, mRNA
Therapeutic Areas
Rare Disease
Metabolic
Quick Facts
HQ:Poland
Founded:2006
Employees:1,414
Capabilities & Services
Core Capabilities
- Biologics Drug Substance
- Biologics Drug Product
- Biologics Manufacturing
Types of Organization
GMP Manufacturing
Quality Systems
Regulatory Support
Dosage Forms
Prefilled Syringe
Sterile Injectable
Containment Capabilities
OEB 5 (≤1 µg/m³)
Cytotoxic / ADC Handling
Production Scales
R&D / Pre-clinical
Lab Scale
Pilot Scale
Markets Served
Asia-Pacific
International Regulatory
EU GMP Certificates
5
Regulatory Bodies
EMA/EudraGMDP
Regulatory Approvals
Drug Approval V7WXEQ
Health Canada · #APR-G4K4W3MZ · 2018-05-01
Case Studies
0 published case studies showcasing past projects, challenges and outcomes.
Certifications
EMA GMP Certificate
European Medicines Agency
Cert #: CERT-VJKKXU3U
Issued: 2020-06-21
Expires: 2025-11-19
Health Canada GMP
Health Canada
Cert #: CERT-87P3ZNAS
Issued: 2020-02-22
Expires: 2025-08-13
Loading CDMO intelligence...
Key facts about Mabion S.A.
- Mabion S.A. is headquartered in Poland.
- Mabion S.A. was founded in 2006.
- Mabion S.A. has 1,414 employees.
- Mabion S.A.'s capabilities include Biologics Drug Substance, Biologics Drug Product and Biologics Manufacturing.
Find CDMOs like Mabion S.A.
Directory pages this company appears in, each with the full list of matching manufacturers.